Basiliximab Intravenous and Indacaterol and glycopyrrolate Inhalation
Determining the interaction of Basiliximab Intravenous and Indacaterol and glycopyrrolate Inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: basiliximab
Brand name: Simulect
Synonyms: Basiliximab
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: Glycopyrrolate and indacaterol (inhalation), Indacaterol and Glycopyrrolate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Basiliximab Intravenous-Indacaterol inhalation
- Basiliximab Intravenous-Indacaterol Maleate
- Basiliximab Intravenous-Indapamide
- Basiliximab Intravenous-Inderal
- Basiliximab Intravenous-Inderal Intravenous
- Basiliximab Intravenous-Inderal LA
- Indacaterol and glycopyrrolate Inhalation-Bavencio
- Indacaterol and glycopyrrolate Inhalation-Baxdela
- Indacaterol and glycopyrrolate Inhalation-Baxdela (Delafloxacin Injection)
- Indacaterol and glycopyrrolate Inhalation-Baxdela (Delafloxacin Tablets)
- Indacaterol and glycopyrrolate Inhalation-Baxdela Intravenous
- Indacaterol and glycopyrrolate Inhalation-Baycadron